• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Aptar Pharma banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

People

Cardiff Scintigraphics names John Pritchard as Chairman of the Board

Cardiff Scintigraphics, has announced the appointment of OINDP expert John Pritchard as the company's Chairman of the Board, succeeding David Owen. The news comes soon after Cardiff Scintigraphics, the parent company of inhalation CRO i2c Pharma Services, named Andrew Brown as CEO, succeeding Glyn Taylor. Pritchard, the 2018 winner of the Charles G. Thiel Award for … [Read more...] about Cardiff Scintigraphics names John Pritchard as Chairman of the Board

1nhaler announces board appointments

Disposable dry powder inhaler developer 1nhaler has announced the appointment of former AstraZeneca VP Jane Gaddum as Board Chair and non-executive director and former GSK VP Gordon Muirhead as a non-executive director. Gaddum was AstraZeneca VP of Global Marketing for Emerging Respiratory and Inflammation from 1997 to 2013, according to her LinkedIn profile. … [Read more...] about 1nhaler announces board appointments

Enterprise Therapeutics names Renu Gupta as Chief Medical Officer

UK-based Enterprise Therapeutics, which is developing inhaled ENaC blockers for the treatment of cystic fibrosis and other respiratory conditions, has named former Insmed Executive VP of Development and Chief Medical Officer Renu Gupta as the company's new CMO. Enterprise also announced the appointment of Janet Hammond, currently Chief Development Officer at Atea … [Read more...] about Enterprise Therapeutics names Renu Gupta as Chief Medical Officer

Cardiff Scintigraphics / i2c name Andrew Brown as CEO

Cardiff Scintigraphics, the parent company of inhalation CRO i2c Pharma Services, has named former OBG Pharmaceuticals Chief Scientific Officer Andrew Brown as CEO, succeeding Glyn Taylor, who will continue part time as Chief Scientific Officer. Brown was most recently Chief Scientific Officer and Operations Director of OBG subsidiary Noveayr Therapeutics, which … [Read more...] about Cardiff Scintigraphics / i2c name Andrew Brown as CEO

Kindeva Drug Delivery names Denis Johnson as Chief Operating Officer

Kindeva Drug Delivery  has announced the appointment of Denis Johnson as Chief Operating Officer. Johnson was most recently Head of Global Manufacturing at Biogen and had previously served in executive roles at Catalent Pharma Solutions and Boston Scientific. The company noted that one of Johnson's focuses will be on Kindeva's efforts around transitioning MDIs to LGWP … [Read more...] about Kindeva Drug Delivery names Denis Johnson as Chief Operating Officer

Kindeva appoints Jenifer Riter as VP of Analytical Services

Kindeva Drug Delivery  has named former West Pharmaceutical Services Senior Director, Business and Technical Operations, Jennifer Riter as VP of Analytical Services. Earlier this year, Kindeva announced the launch of its new analytical services business, which will offer medical device, container closure, and extractables and leachables testing. Riter worked in … [Read more...] about Kindeva appoints Jenifer Riter as VP of Analytical Services

Vast announces appointments in preparation for clinical development of ALX1 inhalation solution

Vast Therapeutics has announced the appointments of former Aradigm Senior Medical Director Paul Bruinenberg as Chief Medical Officer and Chris Polage as Medical Director in preparation for clinical development of its ALX1 inhalation solution. Bruinenberg was most recently Senior Medical Officer of the TB Alliance. In addition to his stint at Aradigm, Bruinenberg's … [Read more...] about Vast announces appointments in preparation for clinical development of ALX1 inhalation solution

Oragenics CEO Kimberly Murphy resigns

Oragenics, which describes itself as "a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders" has announced the resignation of CEO Kimberly Murphy as part of "a mutually agreeable Separation Agreement." The company specified that Murphy's resignation "was not due to any disagreement with the Company … [Read more...] about Oragenics CEO Kimberly Murphy resigns

Adherium announces the appointment of Paul Mastoridis as CEO

Adherium has announced that former Novartis executive Paul Mastoridis will succeed Rick Legleiter as CEO of the Hailie inhaler monitoring system maker. Legleiter recently announced his resignation from the company. Mastoridis was most recently Global Medical Head of Respiratory at Novartis and previously served as a brand director for respiratory at that company. … [Read more...] about Adherium announces the appointment of Paul Mastoridis as CEO

Gary Pitcairn joins Iconovo as Senior Scientific Advisor

Iconovo has announced that OINDP expert Gary Pitcairn will join the company as Senior Scientific Advisor to support development projects, particularly reformulation of drugs for inhalation. Pitcairn, who was most recently Chief Scientific Officer at Nanologica, previously headed respiratory groups at AstraZeneca, Mylan, Pfizer, and Pharmaceutical Profiles. He is also … [Read more...] about Gary Pitcairn joins Iconovo as Senior Scientific Advisor

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 39
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Merxin We Make Inhalers banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews